Vascular targeting effects of ZD6126 in A C3H mouse mammary carcinoma and the enhancement of radiation responseHORSMAN, Michael R; MURATA, Rumi.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 4, pp 1047-1055, issn 0360-3016, 9 p.Conference Paper

Combination of vascular targeting agents with thermal or radiation therapyHORSMAN, Michael R; MURATA, Rumi.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1518-1523, issn 0360-3016, 6 p.Conference Paper

Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiationHORSMAN, Michael R; MURATA, Rumi; OVERGAARD, Jens et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 4, pp 497-503, issn 0284-186XArticle

Combretastatin A-4 disodium phosphate: A vascular targeting agent that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapyMURATA, Rumi; OVERGAARD, Jens; HORSMAN, Michael R et al.International journal of radiation oncology, biology, physics. 2001, Vol 51, Num 4, pp 1018-1024, issn 0360-3016Article

Angiogenesis and vascular targeting : Relevance for hyperthermiaHORSMAN, Michael R.International journal of hyperthermia. 2008, Vol 24, Num 1, pp 57-65, issn 0265-6736, 9 p.Conference Paper

Vascular-targeting therapies for treatment of malignant diseaseSIEMANN, Dietmar W; CHAPLIN, David J; HORSMAN, Michael R et al.Cancer. 2004, Vol 100, Num 12, pp 2491-2499, issn 0008-543X, 9 p.Article

Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopyNIELSEN, Flemming U; DAUGAARD, Preben; BENTZEN, Lise et al.Cancer research (Baltimore). 2001, Vol 61, Num 13, pp 5318-5325, issn 0008-5472Article

Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin LCHAVARRIA, Gustavo E; HORSMAN, Michael R; ARISPE, Wara M et al.European journal of medicinal chemistry. 2012, Vol 58, pp 568-572, issn 0223-5234, 5 p.Article

Assessment of hypoxia in experimental mice tumours by [¹⁸F]Fluoromisonidazole PET and pO₂ electrode measurements: Influence of tumour volume and carbogen breathingBENTZEN, Lise; KEIDING, Susanne; HORSMAN, Michael R et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 3, pp 304-312, issn 0284-186XArticle

Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine outputBOHN, Anja B; NØRREGAARD, Rikke; STØDKILDE-JØRGENSEN, Hans et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2012, Vol 72, Num 1, issn 0363-6119, R186-R198Article

Aerobic glycolysis in cancers : Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxiaBUSK, Morten; HORSMAN, Michael R; KRISTJANSEN, Paul E. G et al.International journal of cancer. 2008, Vol 122, Num 12, pp 2726-2734, issn 0020-7136, 9 p.Article

The Relationship between Tumor Blood Flow, Angiogenesis, Tumor Hypoxia, and Aerobic GlycolysisØSTERGAARD, Leif; TIETZE, Anna; NIELSEN, Thomas et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 18, pp 5618-5624, issn 0008-5472, 7 p.Article

Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecanHASSELBALCH, Benedikte; GRAU ERIKSEN, Jesper; BROHOLM, Helle et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2010, Vol 118, Num 8, pp 585-594, issn 0903-4641, 10 p.Article

Differentiation and definition of vascular-targeted therapiesSIEMANN, Dietmar W; BIBBY, Michael C; DARK, Graham G et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 416-420, issn 1078-0432, 5 p., 1Article

Evaluation of anti-vascular therapy with texture analysisGANG CHEN; JESPERSEN, Sune; PEDERSEN, Michael et al.Anticancer research. 2005, Vol 25, Num 5, pp 3399-3405, issn 0250-7005, 7 p.Article

Feasibility of detecting hypoxia in experimental mouse tumours with ¹⁸F-fluorinated tracers and positron emission tomography : A study evaluating [¹⁸F]Fluoromisonidazole and [¹⁸F]fluoro-2-deoxy-D-glucoseBENTZEN, Lise; KEIDING, Susanne; HORSMAN, Michael R et al.Acta oncologica (Stockholm). 2000, Vol 39, Num 5, pp 629-637, issn 0284-186XArticle